Market Overview

Gordon Johnson Lowers Tesla Price Target To $93, Says Sales Will Suffer Between 2019 And 2020

Share:
Gordon Johnson Lowers Tesla Price Target To $93, Says Sales Will Suffer Between 2019 And 2020
Related TSLA
Gene Munster Talks Apple, Amazon-Target, Tesla On PreMarket Prep
Trump Threatens European Auto Tariffs, But May Have Himself To Blame For Record Trade Deficit
Ford to Partner With Walmart to Design Driverless Delivery Vehicles (GuruFocus)

Street experts aren’t convinced Tesla Inc (NASDAQ: TSLA) will post profits and positive free cash flow in the third and fourth quarters.

The stock’s most bearish analyst expects lay investors will soon reach the same conclusion.

The Rating

Vertical Group’s Gordon Johnson maintained a Sell rating on Tesla and lowered his price target from $99 to $93.

The Thesis

After comparing Tesla’s quarterly new orders and total unfilled reservations, “we surmise that either Model 3 cancellation rates have spiked from the initial euphoria period of 3/31/16-to-4/30/16, or new reservations have virtually disappeared,” Johnson wrote in a note.

He expects Tesla to exhaust all pre-orders in the first quarter of 2019 — around which time it will begin selling the cheaper Model 3 edition and slice its average selling price.

At the same time, Tesla’s 33-percent year-to-date market share concession in Europe indicates imminent competition in electric vehicles could stunt U.S sales across all models. These factors bode poorly for company fundamentals, according to Vertical.

Sales Will Struggle

“In short, we believe TSLA’s ability to show material revenue growth beyond 1Q19 will prove extremely difficult,” Johnson wrote. “In fact, until new products are introduced (i.e., likely 3 years from now, or 2021), we see TSLA’s ability to continue growing sales in the double-digit percentage range beyond 1Q19 as acutely compromised.”

Even assuming Tesla sells an aggressive $120,000 in ZEV credits in the third and fourth quarters, along with $120 million in other high-margin regulatory credit sales, the analyst anticipates earnings before interest and taxes of -$304 million and -$119 million, respectively.

Johnson expects 2018 upside to Tesla’s Powerwall and Powerpack sales in Puerto Rico, but considers the estimated $58 million opportunity inconsequential against Tesla’s cash burn.

Price Action

At time of publication, Tesla shares were trading up 1 percent at $348.34. A Form 4 filing late Wednesday showed that CEO Elon Musk bought 72,500 shares at an average price ranging from $342.44 to $347.44.

Related Links:

Tesla Lays Off 9% Of Workforce, Declines To Renew Home Depot Contract

Keybanc Says Tesla Deliveries Tracking Above Estimates, Raises Model 3 Deliveries Forecast To 30,000

Latest Ratings for TSLA

DateFirmActionFromTo
Oct 2018Canaccord GenuityMaintainsHoldHold
Oct 2018JMP SecuritiesInitiates Coverage OnMarket Outperform
Oct 2018MacquarieInitiates Coverage OnOutperform

View More Analyst Ratings for TSLA
View the Latest Analyst Ratings

Posted-In: Gordon Johnson Model 3 Vertical GroupAnalyst Color Price Target Reiteration Top Stories Analyst Ratings Best of Benzinga

 

Related Articles (TSLA)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
LXFTKeyBancDowngrades0.0
CPAImperial CapitalDowngrades68.0
PRMWImperial CapitalInitiates Coverage On18.0
TGTKeyBancInitiates Coverage On110.0
QCOMMorgan StanleyUpgrades0.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Benzinga Pro's 5 Stocks To Watch Today

Benzinga's Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma's Q4 Miss, Sage Inks Deal With Japan's Shionogi